miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON

Hepatology Research

Volumn 45, Issue 13, 2015, Pages 1312-1322

  Sun, Huiyan ^a   Cui, Chunping ^a   Xiao, Fengjun ^a   Wang, Hua ^a   Xu, Jun ^a   Shi, Xuefeng ^a   Yang, Yuefeng ^a   Zhang, Qunwei ^a   Zheng, Xiaofei ^a   Yang, Xiaoming ^a   Wu, Chutse ^a,b   Wang, Lisheng ^a,b  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b Department of Respiratory Medicine Qinghai Provincial People s Hospital   (China)

Author keywords

CITRON; CLDN10; Hepatocellular carcinoma; Migration; miRNA 486; Sorafenib

Indexed keywords

MATRIX METALLOPROTEINASE; MICRORNA; MICRORNA 486; SORAFENIB; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CITRON GENE; CLDN10 GENE; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR INVASION;

EID: 84955191354     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12500     Document Type: Article

References (28)

1. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-87.
2. Diederichs S, Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007; 131: 1097-108.
3. Saito Y, Hibino S, Saito H. Alterations of epigenetics and microRNA in hepatocellular carcinoma. Hepatol Res 2014; 44: 31-42.
4. Gaur A, Jewell DA, Liang Y et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67: 2456-68.
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
6. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.
7. Liu X, Sempere LF, Ouyang H et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010; 120: 1298-309.
8. Lee KH, Chen YL, Yeh SD et al. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 2009; 28: 3360-70.
9. Gramantieri L, Fornari F, Callegari E et al. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008; 12: 2189-204.
10. Fornari F, Gramantieri L, Giovannini C et al. miR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009; 69: 5761-7.
11. Shimizu S, Takehara T, Hikita H et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010; 52: 698-704.
12. Li Y, Tan W, Neo TW et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-42.
13. Wong CC, Wong CM, Tung EK et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011; 140: 322-31.
14. Pogribny IP, Starlard-Davenport A, Tryndyak VP et al. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 2010; 90: 1437-46.
15. Noh JH, Chang YG, Kim MG et al. miR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett 2013; 335: 455-62.
16. Small EM, O'Rourke JR, Moresi V et al. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A 2010; 107: 4218-23.
17. Fu H, Tie Y, Xu C et al. Identification of human fetal liver miRNAs by a novel method. FEBS Lett 2005; 579: 3849-54.
18. Xu J, Li R, Workeneh B, Dong Y, Wang X, Hu Z. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int 2012; 82: 401-11.
19. Mosakhani N, Sarhadi VK, Borze I et al. MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 2012; 51: 1-9.
20. Wang XH. MicroRNA in myogenesis and muscle atrophy. Curr Opin Clin Nutr Metab Care 2013; 16: 258-66.
21. Oh HK, Tan AL, Das K et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 2011; 17: 2657-67.
22. Wang J, Tian X, Han R et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 2014; 33: 1181-1189.
23. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
24. Suh Y, Yoon CH, Kim RK et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 2013; 22: 4873-4882.
25. Madaule P, Eda M, Watanabe N et al. Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature 1998; 394: 491-4.
26. Fu Y, Huang J, Wang KS, Zhang X, Han ZG. RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells. Mol Biol Rep 2011; 38: 693-702.
27. Ip YC, Cheung ST, Lee YT, Ho JC, Fan ST. Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells. Mol Cancer Ther 2007; 6: 2858-67.
28. Jou J, Diehl AM. Epithelial-mesenchymal transitions and hepatocarcinogenesis. J Clin Invest 2010; 120: 1031-4.